DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Mora PAR, Sun SY, Velarde GC, Rezende FilhoJ, Uberti EH, Esteves AP. et al.
Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?.
Gynecol Oncol 2019;
153 (02) 277-285
DOI: 10.1016/j.ygyno.2019.03.005.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.